|
Managing drug accountability
McKesson Specialty, San Rafael, CA
Protecting human research subjects is your single most important duty when conducting clinical trials in your practice. You are well on the road to protecting human subjects when you can ensure that a qualified institutional review board or ethics committee approves the conduct of the study, you obtain informed consent from each patient enrolled, and you accurately manage and document drug accountability. This article focuses on the last task, with specific steps and tips you can tailor to your practice.
| Commun Oncol 2007;4:487–489 | full text |  96 kb |